Publicacions en col·laboració amb investigadors/es de Universidad de Buenos Aires (24)

2023

  1. Food Insecurity and Chronic Kidney Disease: Considerations for Practitioners

    Journal of Renal Nutrition, Vol. 33, Núm. 5, pp. 691-697

  2. Targeting FOXP3 Tumor-Intrinsic Effects Using Adenoviral Vectors in Experimental Breast Cancer

    Viruses, Vol. 15, Núm. 9

  3. mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy

    Cell Reports Medicine, Vol. 4, Núm. 3

2022

  1. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

    The Lancet Oncology, Vol. 23, Núm. 7, pp. e334-e347

  2. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

    Critical Care, Vol. 26, Núm. 1

  3. Variations in management of A3 and A4 cervical spine fractures as designated by the AO Spine Subaxial Injury Classification System

    Journal of Neurosurgery: Spine, Vol. 36, Núm. 1, pp. 99-112

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. SPARC inhibition accelerates NAFLD-associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism

    Liver International, Vol. 41, Núm. 7, pp. 1677-1693

  3. Worldwide barriers to genetic testing for movement disorders

    European Journal of Neurology, Vol. 28, Núm. 6, pp. 1901-1909

2020

  1. Should breast reconstruction and breast oncoplastic procedures be performed during the coronavirus pandemic?

    ecancermedicalscience, Vol. 14

2018

  1. Treatable inherited rare movement disorders

    Movement Disorders, Vol. 33, Núm. 1, pp. 21-35

2017

  1. Therapeutic blockade of Foxp3 in experimental breast cancer models

    Breast Cancer Research and Treatment, Vol. 166, Núm. 2, pp. 393-405

2012

  1. Reconstructing Native American population history

    Nature, Vol. 488, Núm. 7411, pp. 370-374

2009

  1. Induction of hepatic aminolevulinate acid synthetase activity by isoflurane in a genetic model for erythropoietic protoporphyria

    Cellular and Molecular Biology, Vol. 55, Núm. 1, pp. 38-44

  2. The Influence of Baseline Parameters on Changes in International Prostate Symptom Score with Dutasteride, Tamsulosin, and Combination Therapy among Men with Symptomatic Benign Prostatic Hyperplasia and an Enlarged Prostate: 2-Year Data from the CombAT Study

    European Urology, Vol. 55, Núm. 2, pp. 461-471

2005

  1. Effects of repeated administration with CP-55,940, a cannabinoid CB 1 receptor agonist on the metabolism of the hepatic heme

    International Journal of Biochemistry and Cell Biology, Vol. 37, Núm. 8, pp. 1620-1625

2004

  1. Volatile anaesthetics induce biochemical alterations in the heme pathway in a B-lymphocyte cell line established from hepatoerythropoietic porphyria patients (LBHEP) and in mice inoculated with LBHEP cells

    International Journal of Biochemistry and Cell Biology, Vol. 36, Núm. 2, pp. 216-222

2002

  1. Inhibitory Effect against Polymerase and Ribonuclease Activities of HIV-reverse Transcriptase of the Aqueous Leaf Extract of Terminalia triflora

    Phytotherapy Research, Vol. 16, Núm. 8, pp. 778-780

1999

  1. Argentine plant extracts active against polymerase and ribonuclease H activities of HIV-1 reverse transcriptase

    Phytotherapy Research, Vol. 13, Núm. 3, pp. 206-209

1998

  1. Reference values of 5-Aminolevulinate dehydrase and Porphobilinogen deaminase in the Spanish population from Madrid

    Ecotoxicology and Environmental Safety, Vol. 39, Núm. 3, pp. 168-171